Abstract
The World Health Organization (WHO) is the global public health arm of the United Nations Organization (UNO). It came formally into existence with the adoption of its Constitution on 7 April 1948, a day now celebrated the world over as World Health day. Because of the indisputable importance of health for human welfare, well-being, flourishing, and the capacity to enjoy the other goods of human life, the WHO is arguably the most important branch or agency of the UNO. The power and influence of the WHO is evident in all countries of the world, and health ministries, as well as medical practitioners, obey it like an oracle and quote its instructions and recommendations with finality. As far as medical science and practice are concerned, the WHO is the foremost regulatory authority in the world.
But, in dealing with novel and controversial issues, especially at the interface between medical science, practice, ethics and regulation, the WHO has sometimes left much to be desired or stood on clearly controversial positions. This can be seen by critically looking at the role played by the WHO during two recent epidemics: the West African Ebola virus epidemic between December 2013 and December 2015, and the Zika virus disease (ZVD) in South America (2015–2016). During these epidemic outbreaks, the WHO organized a number of emergency meetings, issued a number of releases and conducted or sponsored a candidate vaccine clinical trial.
In this chapter, we make an appraisal of the roles played by the WHO during the West African Ebola epidemic and the South American Zika outbreak. We critically review various releases and recommendations of the WHO and its sponsorship of a candidate Ebola vaccine, as the epidemics unfolded. And finally, we review its current organization, structures and functioning and suggest changes that may strengthen and empower it in its roles and responsibilities as the most important branch of the UNO in an emergent globalized world.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
See www.gobata.com “Ebola Epidemic: the WHO gets it right, then wrong” October 09, 2014.
- 2.
See www.gobata.com “WHO DONE IT AGAIN!” September 07, 2015.
- 3.
ibid.
- 4.
ibid.
- 5.
ibid.
- 6.
ibid.
References
Bearcroft, W. G. C. (1954). Zika virus infection experimentally induced in a human volunteer. Transaction of the Royal Society of Tropical Medicine and Hygiene., 50(5), 442–447.
Cheri, G., & Kyle, M. (2009). Comparative advantages of push and pull incentives for technology development: Lessons for neglected disease technology development. Global Forum Update on Research for Health, 6, 147–151.
Emanuel, E., et al. (Eds.). (2003). Ethical and regulatory aspects of clinical research: Readings and commentary. Baltimore/London: The Johns Hopkins University Press.
Ezeome, E. R., & Simon, C. (2010). Ethical problems in conducting research in acute epidemics: The Pfizer meningitis study in Nigeriaas an illustration. Developing World Bioethics, 10(1), 1–10.
Farar, J. (2015). The Ebola vaccine we dared to dream of is here. Available online: Accessed 14 March 2017.
Henao-Restrepo, et al. (2015). Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: Interim results from the Guinea ring vaccination cluster-randomised trial. The Lancet, 386(999), 857–866.
MacNamara, F. N. (1954). Zika virus: A report on three cases of human infection during an epidemic of jaundice in Nigeria. Transaction of the Royal of Society Tropical Medicine and Hygiene, 48, 139–145.
WHO. (2016). Zika virus outbreak global response: Interim report. Available online: Accessed 6 March 2017.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Tangwa, G.B., Afolabi, M.O. (2019). Global Emerging Pathogens and the (Prescriptive) Role of the World Health Organization. In: Tangwa, G., Abayomi, A., Ujewe, S., Munung, N. (eds) Socio-cultural Dimensions of Emerging Infectious Diseases in Africa. Springer, Cham. https://doi.org/10.1007/978-3-030-17474-3_10
Download citation
DOI: https://doi.org/10.1007/978-3-030-17474-3_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-17473-6
Online ISBN: 978-3-030-17474-3
eBook Packages: MedicineMedicine (R0)